Goodbody Health partners with Datar to Offer Innovative Cancer Screening

Goodbody Health Limited
(“Goodbody Health”, or the “Company”)

Goodbody Health partners with Datar to Offer Innovative Cancer Screening


 Goodbody Health (AQSE: GDBY) is pleased to announce that it has partnered with Datar Cancer Genetics (“Datar”) a world-leading liquid biopsy company to offer its innovative Circulating Tumor Cell (CTC) based multi-cancer screening solution Trucheck in the UK. 

According to Dr Vineet Datta, Executive Director at Datar Cancer Genetics, “There is clear evidence that cancer screening led early detection saves lives and leads to a less radical treatment with fewer side effects. Analysis of CTCs using our advanced technology through this innovative platform allows highly sensitive detection of cancer at early stages. Trucheck is a CE certified cancer screening solution offered for single and multi-organ cancer screening. We believe the solution will encourage more men and women to participate in cancer screening for a safer future. Working with Goodbody brings this screening service one-step closer to the general public.”

George Thomas, Chief Executive Officer, said: “Trucheck offers a paradigm shift in cancer screening through a novel process of utilising CTCs to identify cancers in both early and advanced stages, with validation from more than 40,000 individuals.  We are excited to work with Datar and to add the Trucheck cancer screening solution to our portfolio of health and wellness tests offered through our clinic network to ensure our customers get the best opportunity to take preventative measures to look after their health, at a convenient and accessible location”.

The Directors of the Company accept responsibility for the contents of this announcement.

George Thomas
Chief Executive Officer
Goodbody Health Limited
+44 (0) 20 7971 1255
[email protected]

AQSE Corporate Advisor
Peterhouse Capital Limited
Guy Miller / Mark Anwyl
+44 (0) 20 7469 0930

Anne Tew
Chief Financial Officer
Goodbody Health Limited
+44 (0) 20 7971 1255
[email protected]

Notes to Editors:

Health Limited (AQSE: GDBY and OTCQB: GDBYF) is an aggregator of the
highest quality, most innovative range of health 
wellness services and products using
the latest technology.  With over 52 products today, tests include blood, genetic, covid and other diagnostic
solutions to meet today’s fast evolving consumer expectations
 with more than 200,000 tests completed to
date. A comprehensive portfolio of CBD based products complement the
wellness range.

as a trusted distributor and retailer of accredited
wellness products and diagnostic services, provid
es a unique ‘frontline’ healthcare service in the
local community 
with expertise to enable customers to manage their health care digitally and make considered choices for their ‘health span’. Our
products and services grow local level amenities through 
a network
of over 200 independent community providers
offering much needed revenue to pharmacists and 
others local
providers, while alleviating pressure on the NHS.


Useful Website and social media links:

Product Link –



Share on

Published on